Similarly, in colorectal cancer, ADM is among the most selectively upregulated genes in KRAS-mutant cells under hypoxia, and its expression is markedly reduced upon KRAS silencing, highlighting ADM as a key downstream effector of KRAS-driven tumorigenesis in hypoxic niches (56). The gene discussed is ADM; the disease is colorectal cancer.